[untitled]
4 comments
What the study actually finds is, yes, myocarditis and pericarditis only happen in adolescents that are vaccinated, BUT that this is offset by significantly lower hospitalization rates in the vaccinated. They also do not find that all myo and pericarditis cases required hospitalization.
The study does NOT look at long-term issues related to either the vaccine or the (usually temporary) myo- and pericarditis, (nor due to long-COVID), and since most cases of myo- and pericarditis resolve, this still for sure means, on net, that the vaccine reduces hospitalizations.
Insofar as most studies tend to show that the long-term sequelae are significantly worse than the long-term sequelae of the vaccine (even if you get temporary myo/pericarditis), it is almost certainly the case that, if you know there is a decent chance you will catch COVID (and there is), there is more risk not being vaccinated than from vaccination.
The only exception to these findings, broadly, that I am aware of, are in severely immunocompromised individuals lacking e.g. B-cells or T-cells, where, there, the effectiveness of the vaccine can be too poor to recommend. For everyone else, it is clear the vaccine reduces risk (though this reduction is far less than we might hope, obviously).
The study does NOT look at long-term issues related to either the vaccine or the (usually temporary) myo- and pericarditis, (nor due to long-COVID), and since most cases of myo- and pericarditis resolve, this still for sure means, on net, that the vaccine reduces hospitalizations.
Insofar as most studies tend to show that the long-term sequelae are significantly worse than the long-term sequelae of the vaccine (even if you get temporary myo/pericarditis), it is almost certainly the case that, if you know there is a decent chance you will catch COVID (and there is), there is more risk not being vaccinated than from vaccination.
The only exception to these findings, broadly, that I am aware of, are in severely immunocompromised individuals lacking e.g. B-cells or T-cells, where, there, the effectiveness of the vaccine can be too poor to recommend. For everyone else, it is clear the vaccine reduces risk (though this reduction is far less than we might hope, obviously).
1] Use the actual title.
2] replacing the title to promote political view rather than reality.
3] repetitively fostering misinformation campaign that does real harm to individuals, society, and multiple species.
4] the article :
Observational Study Epidemiology
. 2026 Jan 1;37(1):141-151. doi: 10.1097/EDE.0000000000001908. Epub 2025 Sep 23.
OpenSAFELY: Effectiveness of COVID-19 Vaccination in Children and Adolescents
this is about using OpenSAFELY to interpret data, and has nothing to do with the supposition of the replacement title.
2] replacing the title to promote political view rather than reality.
3] repetitively fostering misinformation campaign that does real harm to individuals, society, and multiple species.
4] the article :
Observational Study Epidemiology
. 2026 Jan 1;37(1):141-151. doi: 10.1097/EDE.0000000000001908. Epub 2025 Sep 23.
OpenSAFELY: Effectiveness of COVID-19 Vaccination in Children and Adolescents
this is about using OpenSAFELY to interpret data, and has nothing to do with the supposition of the replacement title.
Indeed, the actual "takeaway":
> Our findings provide insights into the balance between protection by vaccination against target outcomes (positive SARS-CoV-2 tests, COVID-19-related hospitalization, and A&E attendance) and the increased risk of pericarditis and myocarditis. In adolescents, the reduction in risk of COVID-19 hospitalization per 10,000 individuals (−1.14 for first dose vs. unvaccinated, −1.45 for second vs. first dose) was larger than the increase in risk of both myocarditis (0.08 for first dose vs. unvaccinated) and pericarditis (0.31 for first dose vs. unvaccinated, 0.21 for second vs. first dose). However, the reduction in risk of COVID-19 hospitalization in children (−0.02 for first dose vs. unvaccinated) was lower than the increase in risk of pericarditis (0.22).
> Our findings provide insights into the balance between protection by vaccination against target outcomes (positive SARS-CoV-2 tests, COVID-19-related hospitalization, and A&E attendance) and the increased risk of pericarditis and myocarditis. In adolescents, the reduction in risk of COVID-19 hospitalization per 10,000 individuals (−1.14 for first dose vs. unvaccinated, −1.45 for second vs. first dose) was larger than the increase in risk of both myocarditis (0.08 for first dose vs. unvaccinated) and pericarditis (0.31 for first dose vs. unvaccinated, 0.21 for second vs. first dose). However, the reduction in risk of COVID-19 hospitalization in children (−0.02 for first dose vs. unvaccinated) was lower than the increase in risk of pericarditis (0.22).
I asked co-pilot to explain it like you were a puppy dog so you can understand.
Okay, here’s the puppy-level version:
Shot = good. Shot helps keep you from getting sick. Sick = bad. Shot makes hospital visits less. Sometimes hearts get a little grumpy, but that’s super rare. Most pups (kids) are totally fine.
Big idea: Shot helps more than it hurts.